Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
QuantumLeap Healthcare Collaborative
Eli Lilly and Company
Revolution Medicines, Inc.
Hoffmann-La Roche
AbbVie
Astellas Pharma Inc
Amgen